|
Volumn 270, Issue 4, 2013, Pages 1397-1404
|
Antitumor effects of Dasatinib on laryngeal squamous cell carcinoma in vivo and in vitro.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
DASATINIB;
PROTEIN KINASE INHIBITOR;
PYRIMIDINE DERIVATIVE;
THIAZOLE DERIVATIVE;
ANIMAL;
APOPTOSIS;
ARTICLE;
CANCER TRANSPLANTATION;
CELL CYCLE;
CELL PROLIFERATION;
CELL TRANSFORMATION;
DOSE RESPONSE;
DRUG EFFECT;
FLOW CYTOMETRY;
HUMAN;
IN VITRO STUDY;
LARYNX TUMOR;
MALE;
MOUSE;
NUDE MOUSE;
PATHOLOGY;
RAT;
SQUAMOUS CELL CARCINOMA;
TUMOR CELL LINE;
WESTERN BLOTTING;
ANIMALS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
APOPTOSIS;
BLOTTING, WESTERN;
CARCINOMA, SQUAMOUS CELL;
CELL CYCLE;
CELL LINE, TUMOR;
CELL PROLIFERATION;
CELL TRANSFORMATION, NEOPLASTIC;
CISPLATIN;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FLOW CYTOMETRY;
HUMANS;
LARYNGEAL NEOPLASMS;
MALE;
MICE;
MICE, NUDE;
NEOPLASM TRANSPLANTATION;
PROTEIN KINASE INHIBITORS;
PYRIMIDINES;
RATS;
THIAZOLES;
|
EID: 84884801845
PISSN: None
EISSN: 14344726
Source Type: None
DOI: 10.1007/s00405-013-2394-3 Document Type: Article |
Times cited : (14)
|
References (0)
|